Rani Therapeutics Holdings, Inc. revenue breakdown overview

Rani Therapeutics Holdings, Inc. revenue for the last year amounted to 1.03 M USD, the most of which — 1.03 M USD — came from its highest performing source at the moment, Orally Administered Biologics, the year earlier bringing 2.72 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Rani Therapeutics Holdings, Inc. 1.03 M USD, and the year before that — 2.72 M USD.